So if Israel did not in fact have a functioning adverse event monitoring system in place and its data was a fiction, and even if when it did launch a proper monitoring system a year too late, with analysis of the system’s findings completely ignored and withheld – what was the FDA really relying on? What were all those regulators relying on?
Yaffa Shir-Raz, PhD, is a risk communication researcher and a teaching fellow at the University of Haifa and Reichman University. Her area of research focuses on health and risk communication, including Emerging Infectious Disease (EID) communication, such as the H1N1 and the COVID-19 outbreaks. She examines the practices used by the pharmaceutical industries and by health authorities and organizations to promote health issues and brand medical treatments, as well as censorship practices used by corporations and by health organizations to suppress dissenting voices in the scientific discourse. She is also a health journalist, and the editor of the Israeli Real-Time Magazine and a member of the PECC general assembly.